Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Robert A. Anders"'
Autor:
Christopher Fan, Ahyoung Kim, Sean Li, Jarushka Naidoo, Laura C. Cappelli, Julie R. Brahmer, Robert A. Anders, Amy K. Kim
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:877-883
Autor:
Hua Zhao, Yulan Cheng, Andrew Kalra, Ke Ma, Yueyuan Zheng, Benjamin Ziman, Caitlin Tressler, Kristine Glunde, Eun Ji Shin, Saowanee Ngamruengphong, Mouen Khashab, Vikesh Singh, Robert A. Anders, Simran Jit, Nicolas Wyhs, Wei Chen, Xu Li, De-Chen Lin, Stephen J. Meltzer
Publikováno v:
Science Translational Medicine. 14
Inactivation of the tumor suppressor genes tumor protein p53 ( TP53 ) and cyclin-dependent kinase inhibitor 2A ( CDKN2A ) occurs early during gastroesophageal junction (GEJ) tumorigenesis. However, because of a paucity of GEJ-specific disease models,
Autor:
Mark Yarchoan, Leslie Cope, Amanda N. Ruggieri, Robert A. Anders, Anne M. Noonan, Laura W. Goff, Lipika Goyal, Jill Lacy, Daneng Li, Anuj K. Patel, Aiwu R. He, Ghassan K. Abou-Alfa, Kristen Spencer, Edward J. Kim, S. Lindsey Davis, Autumn J. McRee, Paul R. Kunk, Subir Goyal, Yuan Liu, Lauren Dennison, Stephanie Xavier, Aditya A. Mohan, Qingfeng Zhu, Andrea Wang-Gillam, Andrew Poklepovic, Helen X. Chen, Elad Sharon, Gregory B. Lesinski, Nilofer S. Azad
Publikováno v:
J Clin Invest
The Journal of clinical investigation, vol 131, iss 24
The Journal of clinical investigation, vol 131, iss 24
BACKGROUND: MEK inhibitors have limited activity in biliary tract cancers (BTCs) as monotherapy but are hypothesized to enhance responses to programmed death ligand 1 (PD-L1) inhibition. METHODS: This open-label phase II study randomized patients wit
Autor:
Ye Yang, Raad Z. Gharaibeh, Payam Fathi, Shaoguang Wu, Liam Chung, Anthony A. Fodor, Sarah Tomkovich, Sepideh Besharati, Marcus Mühlbauer, James R. White, Jillian L. Pope, Cynthia L. Sears, Ernesto Perez-Chanona, Drew M. Pardoll, Julia L. Drewes, Kathryn Winglee, Xinqun Wu, Robert A. Anders, Christian Jobin, Franck Housseau, Christine M. Dejea, Hao Wang, Xiaolun Sun, Josee Gauthier, Xiuli Liu, Hua Ding
Publikováno v:
Journal of Clinical Investigation. 129:1699-1712
Mucus-invasive bacterial biofilms are identified on the colon mucosa of approximately 50% of colorectal cancer (CRC) patients and approximately 13% of healthy subjects. Here, we test the hypothesis that human colon biofilms comprise microbial communi
Autor:
Robert A. Anders, Andrew M. Cameron, Benjamin Philosophe, Christos S. Georgiades, Behnam Saberi, Shane Ottmann, Ahmet Gurakar, Kiyoko Oshima, Amy K. Kim, Merve Gurakar, Michelle Ma, Jacqueline Garonzik-Wang
Publikováno v:
Annals of Hepatology, Vol 17, Iss 6, Pp 1052-1066 (2018)
Ilntroduction and aims. We aimed to investigate the clinical and pathological differences between low-AFP-secreting (AFP < 20 ng/mL) and high-AFP-secreting (AFP ≥ 20 ng/mL) hepatocellular carcinomas in patients who undergo liver transplant (LT). MA
Publikováno v:
American Journal of Clinical Pathology. 151:226-230
Objectives It is challenging to separate peritumoral fibrosis from fibrosis due to chronic liver disease in mass-directed liver biopsies. We evaluated the distance that peritumoral fibrosis extends from metastatic colorectal adenocarcinoma in liver.
Publikováno v:
Journal of Clinical Nursing
SARS‐CoV‐2, the virus that causes COVID‐19, is wreaking havoc around the world. This unprecedented pandemic has led to illness, death, and economic destruction. The pandemic has challenged health care systems globally for a range of reasons. In
Autor:
Mounes Aliyari Ghasabeh, Ankur Pandey, Pegah Khoshpouri, Ihab R. Kamel, Bita Hazhirkarzar, Sanaz Ameli, Maryam Ghadimi, Mohammadreza Shaghaghi, Roya Rezvani Habibabadi, Pallavi Pandey, Robert A. Anders
Publikováno v:
European radiology. 30(7)
We aimed to evaluate the role of volumetric ADC (vADC) and volumetric venous enhancement (vVE) in predicting the grade of tumor differentiation in hepatocellular carcinoma (HCC). The study population included 136 HCC patients (188 lesions) who had ba
Autor:
Manijeh Zarghampour, Robert A. Anders, Mounes Aliyari Ghasabeh, Farnaz Najmi Varzaneh, Ankur Pandey, Ihab R. Kamel, Pegah Khoshpouri, Robert P. Liddell, Pallavi Pandey, Nannan Shao, Daniel Fadaei Fouladi
Publikováno v:
European Radiology. 28:3032-3040
To investigate whether volumetric enhancement on baseline MRI and volumetric oil deposition on unenhanced CT would predict HCC necrosis and response post-TACE. Of 115 retrospective HCC patients (173 lesions) who underwent cTACE, a subset of 53 HCC pa
Autor:
Janis M. Taube, Yong Liang, Xiangyan Qiu, Kien Nham, Yahong Xiong, Mingyi Chen, Xiankai Sun, Yang Xin Fu, Susan M. Harrington, Haidong Tang, Aditi Mulgaonkar, William Silvers, Xin Liu, Raquibul Hannan, Yangchun Xin, Jingya Guo, Haidong Dong, Robert A. Anders, Jian Qiao, Hua Peng, Guiyang Hao
Publikováno v:
Journal of Clinical Investigation. 128:580-588
Programmed death–ligand 1 (PD-L1) expression on tumor cells is essential for T cell impairment, and PD-L1 blockade therapy has shown unprecedented durable responses in several clinical studies. Although higher expression of PD-L1 on tumor cells is